Suppr超能文献

MKP1介导HER2阳性乳腺肿瘤的治疗耐药性。

MKP1 mediates resistance to therapy in HER2-positive breast tumors.

作者信息

Candas Demet, Li Jian Jian

机构信息

School of Medicine; Department of Radiation Oncology; NCI-designated Comprehensive Cancer Center; University of California Davis ; Sacramento, CA, USA.

出版信息

Mol Cell Oncol. 2015 Jan 23;2(4):e997518. doi: 10.1080/23723556.2014.997518. eCollection 2015 Oct-Dec.

Abstract

Mitogen-activated protein kinase phosphatase 1 (MKP1 or DUSP1) is an antiapoptotic phosphatase that is overexpressed in many cancers, including breast cancer. MKP1 expression is inducible in radiation-treated breast cancer cells, and correlates with human epidermal growth factor receptor 2 (ERBB2, HER2) expression. The role of MKP1 in therapy resistance suggests that targeting MKP1 in HER2-positive breast tumors may significantly enhance the efficacy of anti-HER2 and other anticancer therapies.

摘要

丝裂原活化蛋白激酶磷酸酶1(MKP1或DUSP1)是一种抗凋亡磷酸酶,在包括乳腺癌在内的许多癌症中均有过表达。MKP1在接受放疗的乳腺癌细胞中可被诱导表达,且与人类表皮生长因子受体2(ERBB2,HER2)的表达相关。MKP1在治疗耐药性中的作用表明,在HER2阳性乳腺肿瘤中靶向作用于MKP1可能会显著提高抗HER2及其他抗癌疗法的疗效。

相似文献

1
MKP1 mediates resistance to therapy in HER2-positive breast tumors.MKP1介导HER2阳性乳腺肿瘤的治疗耐药性。
Mol Cell Oncol. 2015 Jan 23;2(4):e997518. doi: 10.1080/23723556.2014.997518. eCollection 2015 Oct-Dec.

引用本文的文献

1
Resistance to Radiotherapy in Cancer.癌症对放疗的抗性
Diseases. 2025 Jan 17;13(1):22. doi: 10.3390/diseases13010022.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验